Skip to content
Back to Investors
CF

Clarendon Fund Managers

Venture Capital

Clarendon Fund Managers manages the equity portion of the Investment Fund for Northern Ireland.

Portfolio

8

companies

By category

  • HealthTech£10.3M
  • ManuTech£3.8M
  • MedTech£2.3M
  • Enterprise Software£2.0M
  • eCommerce£1.4M
  • Other£1.4M

By location

  • Belfast£11.7M
  • London£3.8M
  • Lisburn£2.3M
  • Edinburgh£2.0M
  • Manchester£1.4M

Portfolio companies

B-Secur

B-Secur

B-Secur develops ECG technology and algorithms for consumer and medical devices.

C

Cirdan

Cirdan provides software and imaging solutions to accelerate and improve disease diagnosis.

Datactics

Datactics

Datactics provides user-friendly data quality and matching software for business users.

FF

Fluid Focus

A screen time productivity app that rewards users for healthier digital habits.

L

Liopa

Liopa develops automated lip-reading technology for video transcription and healthcare communication.

RR

Reform RX

Reform RX produces digitally connected Pilates equipment equipped with biometric tracking technology.

View all 8 companies

Team

BC

Brian Cummings

Investment Director

Brian serves as investment director at Clarendon Fund Managers and holds non executive director roles across several companies.

LinkedIn
JC

Jim Curran

LinkedIn
Claudine Owens

Claudine Owens

Investment Manager

LinkedIn
JW

Jill Wilson

Investment Associate

Stuart Gaffikin

Stuart Gaffikin

Investment Director

Stuart brings investment, corporate banking, and accounting experience from roles at Clarendon Fund Managers, Bank of Ireland, BDO Northern Ireland, and Moore Stephens. He also serves as a referee for the Irish Rugby Football Union.

LinkedIn
Matthew Ward

Matthew Ward

Investment Manager

Matthew brings venture and financial due diligence experience from his time at Clarendon Fund Managers and PwC. He is an ACA and a board trustee.

LinkedIn
View all 7 team members
NS

Neil Simms

Manager


Recent investments

Pre-Seed
£640K

The Belfast-based app developer has closed a pre-seed round to scale its team and enter the US market.

"The reality is the big tech companies have monetised our time and attention. Every second spent on their platforms translates to revenue. The incentivisation model is all wrong, which is why we as a society are realising a broad range of negative outcomes, from diminishing attention spans to rising anxiety and body image issues. Our mission is to restore individual agency, empowering people to lead healthy, intentional and fulfilling lives."
— Connor Mason, Co-Founder
Seed
£1.4M

The female-founded corporate gifting platform has closed a seed round backed by Clarendon Fund Managers and Techstart Ventures.

"Needi's seamless, tech-driven solution to sourcing high quality, unique gifts has the potential to revolutionise corporate gifting strategies."
— Claudine Owens, Investment Manager
Other
£3.8M

Clarendon Fund Managers led the £3.8m financing round to support international growth and product development.

"With Neal and Yvette at the helm, Reform RX is an ambitious company that shares our vision for the future. It will be the must-have piece of equipment for every Reformer Pilates enthusiast and studio. The deal is the largest initial investment we have ever completed in a single NI company here at Clarendon, which is a reflection of the confidence we have in the team at Reform RX. I can’t wait to see how their journey develops from here."
— Claudine Owens, Investment Manager
£2.3M

The investment was led by Kernel Capital to support operational expansion ahead of new contract wins.

"I would like to take this opportunity to thank our investors for their continued support. This in addition to securing several new contracts will be used to accelerate our operational expansion and deliver on our strong order book for 2023 and beyond."
— Stephen Dunniece, Director